DeSantis Damon 4

What Happened
Damon DeSantis, reported as a 10% owner of Integrated Biopharma, received two gift transfers on April 15, 2026: 8,966,547 shares and 2,235,417 shares of common stock, for a combined total of 11,201,964 shares. Both transfers were recorded at $0.00 per share (transaction code G), so no cash changed hands. Footnotes state the shares were moved into CDDS 2.0, LLC, a Florida LLC controlled by DeSantis.

Key Details

• Transaction date: 2026-04-15; Filing date: 2026-04-17 (filed within the normal two-business-day window).
• Shares transferred: 8,966,547 and 2,235,417 (total 11,201,964); price per share recorded as $0.00.
• Transfer recipients/sources (per footnotes): from CD Financial, LLC (8,966,547) and the Carl DeSantis Revocable Trust (2,235,417) to CDDS 2.0, LLC (controlled by the reporting person).
• Transaction code: G (Gift).
• Shares owned after transaction: not specified in the excerpt provided; see the full Form 4 filing for post-transaction holdings.
• No 10b5-1 plan, tax withholding, or option exercise noted in this filing.

Context
Gifts (code G) are transfers and do not necessarily indicate insider sentiment about the company’s prospects; they can reflect estate planning, intra-family transfers, or entity reorganizations. As a 10% owner, this is a principal-level transfer rather than a routine executive buy/sell; the movement to an LLC he controls suggests internal restructuring or trust-to-entity transfer rather than an open-market purchase or sale.